This inventor holds 1 USPTO granted patent. Top assignee: Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jiale Shen: Innovator in Pharmaceutical Development
Introduction
Jiale Shen is a notable inventor in the field of pharmaceuticals, recognized for his contributions to drug development. He is currently associated with Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd., where he focuses on innovative solutions for medical treatments.
Latest Patents
Jiale Shen holds a patent for a GLP-1/GIP dual agonist, which includes the preparation method and its use. This invention is significant in the realm of diabetes treatment and metabolic disorders, showcasing his expertise and commitment to advancing healthcare.
Career Highlights
Throughout his career, Jiale Shen has demonstrated a strong dedication to research and development. His work at Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. has positioned him as a key player in the pharmaceutical industry, contributing to the advancement of therapeutic options.
Collaborations
Jiale Shen collaborates with talented individuals such as Nan Zhang and Chunhua Jiang, who contribute to the innovative environment at their company. Their teamwork fosters a culture of creativity and excellence in pharmaceutical research.
Conclusion
Jiale Shen's contributions to the field of pharmaceuticals, particularly through his patent on the GLP-1/GIP dual agonist, highlight his role as an influential inventor. His work continues to impact the industry positively, paving the way for future innovations in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile